Voyager Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:VYGR) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -96.72 M-53.52 M-12.51 M77.92 M-15.31 M-132.47 M -127.99 M Cash from investing activities 113 M65.91 M-7.34 M-141.64 M-94.86 M125.45 M 92.35 M Cash from financing activities 3.16 M612 K1.11 M33.65 M114.02 M816 K 4.07 M Free cash flow -96.72 M-53.52 M-12.51 M77.92 M-15.31 M-135.06 M -129.94 M

News

Voyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue Estimates

Voyager Therapeutics (VYGR): 'Strong Buy' On Inflection Points For VY7523 In AD For 2026

Voyager Therapeutics, Inc. (VYGR) Presents at Stifel 2026 Virtual CNS Forum Transcript

Truist reiterates Buy on Voyager Therapeutics stock ahead of data

Voyager Therapeutics (VYGR) Reports Q4 Loss, Beats Revenue Estimates

Voyager Therapeutics Inc earnings beat by $0.05, revenue topped estimates

Lineage Cell (LCTX) Reports Break-Even Earnings for Q4

Voyager Therapeutics, Inc. (VYGR) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript

Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates

Alzheimer's Clinical Trial Results, Sadly Running True To Form

J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline - Johnson & Johnson (NYSE:JNJ)

Voyager Therapeutics stock price target lowered to $25 at H.C. Wainwright